What is Rhythm Pharmaceuticals, Inc.'s EBITDA?

Rhythm Pharmaceuticals, Inc. (RYTM) reported EBITDA of -$43.93M in Q3 2021.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Rhythm Pharmaceuticals, Inc. RYTM EBITDA

EBITDA at other companies

Eli LillyLLY

——

Mirum Pharmaceuticals, Inc.MIRM

——

Arrowhead ResearchARWR

——

AlkermesALKS

——

Praxis Precision Medicines, Inc.PRAX

——

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$60.1M+83.8%

Gross profit$53.0M+82.3%

Operating income-$52.4M-11.4%

Net income-$55.6M-12.4%

EPS (diluted)-$0.83-2.5%

Balance sheet

See full

Cash & equivalents$62.1M-41.4%

Total debt$112.3M-1.1%

Total equity$122.9M+549%

Total assets$442.3M+14.4%

Cash flow

See full

Operating cash flow-$44.2M-9.5%

CapEx$238.3K—

Free cash flow-$29.2M-2.4%

Valuation

See full

Market cap$6.64B+77.3%

Enterprise value$6.69B+78.4%

P/S30.6×+3.2×

Profitability

See full

Gross margin89.4%-0.2pp

Operating margin-90.9%-19.8pp

Net margin-93.3%-18.2pp

FCF margin-61.5%-14.1pp

Returns & leverage

See full

Return on equity-285.8%-68.9pp

Debt / equity0.9×-5.1×

Current ratio4.2×+0.9×

Where this comes from

Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.

−$44.2Mebit+

$315.0KDepreciation Depletion & Amortization

=-$43.93M

The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed November 8, 2022, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s EBITDA?: Rhythm Pharmaceuticals, Inc. (RYTM) reported EBITDA of -$43.93M in Q3 2021.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.